Rehmann Capital Advisory Group’s Idexx Laboratories IDXX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-396
| Closed | -$268K | – | 694 |
|
|
2025
Q4 | $268K | Sell |
396
-10
| -2% | -$6.81K | 0.01% | 557 |
|
|
2025
Q3 | $259K | Hold |
406
| – | – | 0.01% | 545 |
|
|
2025
Q2 | $218K | Sell |
406
-133
| -25% | -$63.6K | 0.01% | 560 |
|
|
2025
Q1 | $226K | Sell |
539
-111
| -17% | -$48.2K | 0.01% | 548 |
|
|
2024
Q4 | $269K | Sell |
650
-229
| -26% | -$100K | 0.02% | 496 |
|
|
2024
Q3 | $445K | Sell |
879
-70
| -7% | -$34K | 0.03% | 370 |
|
|
2024
Q2 | $462K | Sell |
949
-36
| -4% | -$18.1K | 0.03% | 341 |
|
|
2024
Q1 | $532K | Buy |
985
+30
| +3% | +$16.4K | 0.04% | 305 |
|
|
2023
Q4 | $530K | Sell |
955
-11
| -1% | -$5.16K | 0.04% | 298 |
|
|
2023
Q3 | $422K | Sell |
966
-54
| -5% | -$26.9K | 0.04% | 328 |
|
|
2023
Q2 | $512K | Sell |
1,020
-17
| -2% | -$8.15K | 0.05% | 298 |
|
|
2023
Q1 | $519K | Buy |
1,037
+83
| +9% | +$39.7K | 0.05% | 296 |
|
|
2022
Q4 | $389K | Buy |
954
+102
| +12% | +$39.6K | 0.04% | 344 |
|
|
2022
Q3 | $278K | Buy |
852
+174
| +26% | +$63.9K | 0.03% | 400 |
|
|
2022
Q2 | $238K | Sell |
678
-4
| -0.6% | -$1.63K | 0.03% | 429 |
|
|
2022
Q1 | $373K | Buy |
682
+31
| +5% | +$16.3K | 0.04% | 364 |
|
|
2021
Q4 | $429K | Sell |
651
-1
| -0.2% | -$628 | 0.04% | 347 |
|
|
2021
Q3 | $405K | Sell |
652
-28
| -4% | -$18.8K | 0.04% | 365 |
|
|
2021
Q2 | $438K | Sell |
680
-105
| -13% | -$58K | 0.04% | 341 |
|
|
2021
Q1 | $391K | Sell |
785
-10
| -1% | -$5.01K | 0.04% | 348 |
|
|
2020
Q4 | $397K | Buy |
795
+28
| +4% | +$12.5K | 0.04% | 306 |
|
|
2020
Q3 | $302K | Buy |
767
+11
| +1% | +$4.07K | 0.04% | 321 |
|
|
2020
Q2 | $250K | Buy |
+756
| New | +$219K | 0.03% | 358 |
|
|
2019
Q3 | $124K | Sell |
456
-220
| -33% | -$61.2K | 0.02% | 400 |
|
|
2019
Q2 | $186K | Hold |
676
| – | – | 0.02% | 452 |
|
|
2019
Q1 | $151K | Hold |
676
| – | – | 0.02% | 479 |
|
|
2018
Q4 | $126K | Buy |
676
+8
| +1% | +$1.64K | 0.02% | 345 |
|
|
2018
Q3 | $167K | Hold |
668
| – | – | 0.02% | 446 |
|
|
2018
Q2 | $146K | Buy |
668
+207
| +45% | +$42.7K | 0.02% | 458 |
|
|
2018
Q1 | $88K | Buy |
+461
| New | +$85.1K | 0.01% | 577 |
|
Other funds holding IDXX
VCM
VPM
Rehmann Capital Advisory Group's IDXX Position: Q1 2026 in Review
Rehmann Capital Advisory Group sold out of Idexx Laboratories (IDXX) in Q1 2026, closing a stake of 396 shares — an estimated $268K sold.
Rehmann Capital Advisory Group first reported a position in IDXX in Q1 2018 and held it in 30 quarters. The position peaked at $532K in Q1 2024. 1,311 funds tracked by Wall St. Rank hold IDXX as of Q1 2026.
- Rehmann Capital Advisory Group reported no remaining Idexx Laboratories position as of Q1 2026 after selling out during the quarter.
- Rehmann Capital Advisory Group sold 396 Idexx Laboratories shares in Q1 2026, an estimated $268K.
- Rehmann Capital Advisory Group first reported a position in Idexx Laboratories in Q1 2018 and held it in 30 quarters.
- Rehmann Capital Advisory Group's Idexx Laboratories position peaked at $532K in Q1 2024.
- 1,311 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2026.
Based on Rehmann Capital Advisory Group's 13F filing for Q1 2026, filed 15 May 2026.